secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2024-07-08T23:59:59+00:00
Accession:  0000105770-24-000055
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West enters $130M incremental term loan to refinance existing debt and notes
----------------------------------------------------------------------------

- On July 2, 2024, West Pharmaceutical Services entered a Third Amendment to its Credit Agreement, establishing a $130.0 million incremental term loan.
- The new term loan was fully drawn at closing and matures on July 2, 2027, with no scheduled amortization.
- Proceeds repaid an outstanding ~$80 million term loan and ~$53 million of 3.82% Series B Senior Notes due July 5, 2024.
- Interest at closing is 3-month SOFR plus 1.250%, with margins ranging from 1.250% to 1.625% based on net leverage ratio.
- Mandatory prepayments apply for asset sales and non-permitted debt issuances; optional prepayments are allowed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000055/0000105770-24-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000055/wst-20240702.htm
  HTML page:      https://secwatch.observer/filing/0000105770-24-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer